|
Name |
Amestolkolide C
|
Molecular Formula | C26H30O9 | |
IUPAC Name* |
[(1R,2S,12S,14R,17R,19R,21S)-2,6,6,14,19-pentamethyl-3,8,15,20-tetraoxo-7,16,18-trioxapentacyclo[12.6.1.02,12.05,10.017,21]henicosa-4,10-dien-11-yl]methyl acetate
|
|
SMILES |
C[C@@H]1C(=O)[C@@H]2[C@@H]3[C@H](O1)OC(=O)[C@@]3(C[C@@H]4[C@@]2(C(=O)C=C5C(=C4COC(=O)C)CC(=O)OC5(C)C)C)C
|
|
InChI |
InChI=1S/C26H30O9/c1-11-21(30)19-20-22(33-11)34-23(31)25(20,5)9-16-14(10-32-12(2)27)13-7-18(29)35-24(3,4)15(13)8-17(28)26(16,19)6/h8,11,16,19-20,22H,7,9-10H2,1-6H3/t11-,16+,19+,20-,22-,25-,26-/m1/s1
|
|
InChIKey |
MZYSDGMJSZVIFW-WIJZQXSHSA-N
|
|
Synonyms |
Amestolkolide C
|
|
CAS | NA | |
PubChem CID | 139590897 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 486.5 | ALogp: | 0.2 |
HBD: | 0 | HBA: | 9 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 122.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 35 | QED Weighted: | 0.428 |
Caco-2 Permeability: | -5.271 | MDCK Permeability: | 0.00002830 |
Pgp-inhibitor: | 0.992 | Pgp-substrate: | 0.053 |
Human Intestinal Absorption (HIA): | 0.065 | 20% Bioavailability (F20%): | 0.748 |
30% Bioavailability (F30%): | 0.575 |
Blood-Brain-Barrier Penetration (BBB): | 0.502 | Plasma Protein Binding (PPB): | 59.60% |
Volume Distribution (VD): | 0.648 | Fu: | 46.32% |
CYP1A2-inhibitor: | 0.016 | CYP1A2-substrate: | 0.09 |
CYP2C19-inhibitor: | 0.086 | CYP2C19-substrate: | 0.213 |
CYP2C9-inhibitor: | 0.054 | CYP2C9-substrate: | 0.03 |
CYP2D6-inhibitor: | 0.008 | CYP2D6-substrate: | 0.046 |
CYP3A4-inhibitor: | 0.507 | CYP3A4-substrate: | 0.638 |
Clearance (CL): | 6.735 | Half-life (T1/2): | 0.781 |
hERG Blockers: | 0.005 | Human Hepatotoxicity (H-HT): | 0.062 |
Drug-inuced Liver Injury (DILI): | 0.879 | AMES Toxicity: | 0.064 |
Rat Oral Acute Toxicity: | 0.801 | Maximum Recommended Daily Dose: | 0.019 |
Skin Sensitization: | 0.598 | Carcinogencity: | 0.771 |
Eye Corrosion: | 0.981 | Eye Irritation: | 0.426 |
Respiratory Toxicity: | 0.961 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003926 | 0.849 | D09WYX | 0.255 | ||||
ENC004709 | 0.818 | D03ZZK | 0.253 | ||||
ENC002931 | 0.579 | D0X4RS | 0.245 | ||||
ENC005628 | 0.569 | D0G7KJ | 0.238 | ||||
ENC003927 | 0.372 | D0D2TN | 0.228 | ||||
ENC005629 | 0.346 | D0Q4SD | 0.228 | ||||
ENC003843 | 0.321 | D0Y2YP | 0.228 | ||||
ENC003163 | 0.306 | D08BDT | 0.222 | ||||
ENC002386 | 0.297 | D02JNM | 0.222 | ||||
ENC002577 | 0.295 | D0KR9U | 0.221 |